• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Jpn J Infect Dis . Evaluation of the detection of other pathogens in hospitalized patients with COVID-19 at a tertiary hospital in Japan

tetano

Editor, Senior Moderator
Jpn J Infect Dis


. 2022 Feb 28.
doi: 10.7883/yoken.JJID.2021.232. Online ahead of print.
Evaluation of the detection of other pathogens in hospitalized patients with COVID-19 at a tertiary hospital in Japan


Michiyo Suzuki[SUP] 1 [/SUP], Kayoko Hayakawa[SUP] 1 2 [/SUP], Yusuke Asai[SUP] 2 [/SUP], Nobuaki Matsunaga[SUP] 2 [/SUP], Mari Terada[SUP] 1 3 [/SUP], Hiroshi Ohtsu[SUP] 3 [/SUP], Ako Toyoda[SUP] 3 [/SUP], Jin Takasaki[SUP] 4 [/SUP], Masayuki Hojo[SUP] 4 [/SUP], Yasuaki Yanagawa[SUP] 5 [/SUP], Sho Saito[SUP] 1 [/SUP], Kei Yamamoto[SUP] 1 [/SUP], Satoshi Ide[SUP] 1 [/SUP], Yutaro Akiyama[SUP] 1 [/SUP], Tetsuya Suzuki[SUP] 1 [/SUP], Ataru Moriya[SUP] 6 [/SUP], Kazuhisa Mezaki[SUP] 6 [/SUP], Norio Ohmagari[SUP] 1 2 [/SUP]



Affiliations

Abstract

The detection of other pathogens in hospitalized coronavirus disease (COVID-19) patients are reported to be infrequent. Considering that the data from Japan is limited, we conducted an observational study including hospitalized COVID-19 patients at the National Center for Global Health and Medicine from January to September 2020. In total, 247 COVID-19 patients were studied. Rapid diagnostic tests such as immunochromatography were performed in 31 (12.6%). Filmarray Respiratory Panel was performed in 18 (7.3%) patients, and none of the tests were positive for pathogens other than severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Respiratory bacterial culture was performed in 66 (26.7%) patients, gram-positive bacteria were identified in 8 (12.1%) patients; gram-negative bacteria, 7 (10.6%) patients, and normal flora, 63 (95.5%) patients. Patients for whom culture was performed were older, more severely ill, and more likely to have radiological evidence of pneumonia on admission. Culture was more frequently performed in the early period of the epidemic than in the later period, without differences in bacterial detection rates. The proportion of viral and bacterial detections among hospitalized COVID-19 patients in tertiary care hospitals in Japan was low. A larger cohort study is necessary to evaluate the effects of each pathogen on the clinical course of COVID-19.

Keywords: COVID-19; bacterial infections; pneumonia.
 
Back
Top Bottom